The impact of age on psoriasis health care in Germany.

about

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.

P2860

Q50193268-0846621F-6783-481D-B50A-ADF8F1FE6B60

P2860

The impact of age on psoriasis health care in Germany.

Item

http://www.wikidata.org/entity/Q39024781

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The impact of age on psoriasis health care in Germany.

@en

The impact of age on psoriasis health care in Germany.

@nl

type

Item

label

The impact of age on psoriasis health care in Germany.

@en

The impact of age on psoriasis health care in Germany.

@nl

prefLabel

The impact of age on psoriasis health care in Germany.

@en

The impact of age on psoriasis health care in Germany.

@nl

P1476

The impact of age on psoriasis health care in Germany.

@en

P2093

A Körber

http://www.w3.org/2001/XMLSchema#string

A Trettel

http://www.w3.org/2001/XMLSchema#string

C Spehr

http://www.w3.org/2001/XMLSchema#string

M Augustin

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

[Impact of sex and age on the clinical and epidemiological aspects of childhood psoriasis: Data from a French cross-sectional multicentre study].

The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.

A weighted polygenic risk score using 14 known susceptibility variants to estimate risk and age onset of psoriasis in Han Chinese

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.

Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis.

Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics.

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.

P304

870-875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDV.14115

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28079929

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt

The impact of age on psoriasis health care in Germany.

about

P2860

P2860

The impact of age on psoriasis health care in Germany.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921